CF Pharmtech Wraps Up Issuance of 21.75 Million New H-Shares
Stock News
Aug 28
CF Pharmtech (02652) has announced the completion of a share issuance, marking a significant step in its capital management strategy.
According to the company's latest disclosure, on 6 August 2026, CF Pharmtech allotted and issued a total of 21,747,700 new H-shares under its general mandate. This move is part of the company's broader efforts to optimize its shareholding structure and support future business growth.
The issuance was carried out in accordance with the company's existing authorization framework, demonstrating a streamlined process that aligns with regulatory requirements and shareholder interests.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.